8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)
Published . Updated .
Filed: 2026-10-15 AccNo: 0001356576-26-000040 Size: 149 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Directly affected
- SUPN Supernus Pharmaceuticals
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-15 AccNo: 0001356576-26-000040 Size: 149 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 15 Oct 2026: Supernus Pharmaceuticals (SUPN) versus the S&P 500
Since the first closing price after “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer),” Supernus Pharmaceuticals (SUPN) is +5.10%. The S&P 500 fund (SPY) is +0.43% over the same days, a +4.67% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.17% | final price |
| GLD | the next day | -0.79% | final price |
| GLD | two days later | -1.15% | still updating |
| GLD | three days earlier | -0.27% | final price |
| GLD | five days earlier | +0.50% | final price |
| QQQ | that day | -2.52% | final price |
| QQQ | the next day | -1.36% | final price |
| QQQ | two days later | -1.67% | still updating |
| QQQ | three days earlier | +2.12% | final price |
| QQQ | five days earlier | +3.17% | final price |
| SPY | that day | -1.09% | final price |
| SPY | the next day | -0.67% | final price |
| SPY | two days later | -0.49% | still updating |
| SPY | three days earlier | +0.81% | final price |
| SPY | five days earlier | +0.87% | final price |
| Supernus Pharmaceuticals (SUPN) | that day | -4.22% | final price |
| Supernus Pharmaceuticals (SUPN) | the next day | +0.62% | final price |
| Supernus Pharmaceuticals (SUPN) | two days later | +2.02% | still updating |
| Supernus Pharmaceuticals (SUPN) | three days earlier | +6.12% | final price |
| Supernus Pharmaceuticals (SUPN) | five days earlier | +7.91% | final price |
| TLT | that day | +0.06% | final price |
| TLT | the next day | -0.66% | final price |
| TLT | two days later | +0.16% | still updating |
| TLT | three days earlier | -2.05% | final price |
| TLT | five days earlier | -2.54% | final price |
Who gains and who loses around Supernus Pharmaceuticals (SUPN)
Companies tied to this story
- SUPN Supernus Pharmaceuticals
Supernus Pharmaceuticals (SUPN) is linked, with no stored direction, high confidence in the 15 Oct 2026 story “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> SUPN
How “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)” reaches Supernus Pharmaceuticals (SUPN)
On 15 Oct 2026, “8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)” is the story that connects Supernus Pharmaceuticals (SUPN) to this story.
The link for Supernus Pharmaceuticals (SUPN) is this: SEC 8-K filing -> direct issuer disclosure -> SUPN
The price range for Supernus Pharmaceuticals (SUPN), and the dates in the story
SUPN traded between 37.54 and 42.52 across 5 sessions. The latest close on file is 39.78.
How strong the case is around Supernus Pharmaceuticals (SUPN)
20 out of 100Price not final
“8-K - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Filer)” scores 20 out of 100. The score uses 1 sources, a +1.29% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.